The Valley Desk

NCT02456740 · Interventional trial

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

Overall registry status Completed

Phase 3

Conditions Migraine

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov